Literature DB >> 7352749

Evidence of plasmid-mediated production of aminoglycoside-modifying enzymes not previously described in Acinetobacter.

B E Murray, R C Moellering.   

Abstract

Two blood culture isolates of Acinetobacter calcoaceticus subsp. anitratus (Herellea vaginicola) were recently observed to be unusually resistant to aminoglycosides. Each strain was found to contain aminoglycoside-modifying enzymes which have not been described previously in this species, including 2"-adenylyltransferase, 3"-adenylyltransferase, 3'-phosphotransferase-III, and 3-acetyltransferase. Treatment of one strain (H-S) with novobiocin led to a loss of resistance to multiple antimicrobial agents and a loss of two aminoglycoside-modifying enzymes; agarose gel electrophoresis of lysates of this strain revealed that the loss of resistance markers was associated with the loss of a large-molecular-weight plasmid. Treatment of the second strain (H-D) with novobiocin produced derivative strains with three different resistance patterns. Agarose gel electrophoresis of deoxyribonucleic acid from crude lysates and from cesium chloride-ethidium bromide gradients of this strain showed only a small plasmid (molecular weight, 5 X 10(6)) common to all variants and failed to explain the loss of resistance markers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7352749      PMCID: PMC283722          DOI: 10.1128/AAC.17.1.30

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Outbreak of a multiply resistant Acinetobacter in a surgical intensive care unit: epidemiology and control.

Authors:  M Castle; J H Tenney; M P Weinstein; T C Eickhoff
Journal:  Heart Lung       Date:  1978 Jul-Aug       Impact factor: 2.210

2.  Isolation of large bacterial plasmids and characterization of the P2 incompatibility group plasmids pMG1 and pMG5.

Authors:  J B Hansen; R H Olsen
Journal:  J Bacteriol       Date:  1978-07       Impact factor: 3.490

3.  Elimination of plasmids from several bacterial species by novobiocin.

Authors:  G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

4.  Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.

Authors:  R C Moellering; C Wennersten; L J Kunz; J W Poitras
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

5.  Clinical studies on a transformation test for identification of Acinetobacter (Mima and Herellea).

Authors:  K Brooks; T Sodeman
Journal:  Appl Microbiol       Date:  1974-06

6.  Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus.

Authors:  E Juni
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

7.  Evaluation of a computer-associated electronic zone analyzer in single-disc antimicrobial susceptibility testing.

Authors:  R C Moellering; B A Mercier; L J Kunz; J W Poitras
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

8.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

9.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

10.  Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors:  R H Glew; R C Moellering; L J Kunz
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

View more
  11 in total

Review 1.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

2.  Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp.

Authors:  T Lambert; G Gerbaud; P Bouvet; J F Vieu; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 3.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.

Authors:  G M Eliopoulos; C Wennersten; S Zighelboim-Daum; E Reiszner; D Goldmann; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

5.  Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Authors:  J Vila; J Ruiz; M Navia; B Becerril; I Garcia; S Perea; I Lopez-Hernandez; I Alamo; F Ballester; A M Planes; J Martinez-Beltran; T J de Anta
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 6.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

7.  Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides.

Authors:  B E Murray; J Tsao; J Panida
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

8.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; A Marcos; F Marco; S Abdalla; Y Vergara; R Reig; R Gomez-Lus; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

9.  Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase.

Authors:  T Lambert; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

10.  Transposon-mediated multiple antibiotic resistance in Acinetobacter strains.

Authors:  M Devaud; F H Kayser; B Bächi
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.